Top

World Journal of Surgical Oncology

Published in:

Open Access 01-12-2018 | Research

The rs1024611 in the CCL2 gene and risk of gynecological cancer in Asians: a meta-analysis

Authors: Shuying He, Xiuzhen Zhang

Published in: World Journal of Surgical Oncology | Issue 1/2018

Abstract

Background

The -2518A/G (rs1024611) polymorphism of the CCL2 (C-C motif chemokine ligand 2), also known as MCP-1 (monocyte chemotactic protein-1) gene, has been reported to be associated with increased gynecological cancer risk, but the results are conflicting.

Methods

In this analysis, 1089 cases and 1553 controls from six publications were used to investigate the association between CCL2-2518A/G (rs1024611) polymorphism and the risk of gynecological cancer with a meta-analytic approach. Studies published on EBSCO, EMBASE, Web of Science, PubMed, SpringerLink, ScienceDirect, Weipu, and CNKI databases were identified (last update was on November 3, 2015). Six articles focused on the association between CCL2-2518A/G (rs1024611) polymorphism, and gynecological cancer risk was selected and data were extracted. The cancer type included endometrial cancer (n = 1), breast cancer (n = 2), ovarian cancer (n = 2), and cervical cancer (n = 1). All statistical analyses were performed using the STATA version 12.0 software.

Results

The meta-analysis showed that CCL2-2518A/G (rs1024611) polymorphism is associated with risk of gynecological cancer (GG vs AG + AA, OR = 1.55, 95%CI = 1.07–2.24, P < 0.05; AA vs GG, OR = 0.59 95%CI = 0.38–0.92, P < 0.05). Notably, the subgroup analysis demonstrated that the genotype AA is associated with a reduced gynecological cancer risk in Asians, but an increased risk when compared to AG in Europeans.

Conclusions

Our data demonstrated the CCL2-2518A/G (rs1024611) polymorphism is significantly associated with risk of gynecological cancer, and the association differs by ethnicity.

Mendes D, Alves C, Afonso N, Cardoso F, Passos-Coelho JL, Costa L, Andrade S, Batel-Marques F. The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer—a systematic review. Breast Cancer Res. 2015;17:140.CrossRefPubMedPubMedCentral

Pan D, Wei K, Ling Y, Su S, Zhu M, Chen G. The prognostic role of Ki-67/MIB-1 in cervical cancer: a systematic review with meta-analysis. Med Sci Monit. 2015;21:882–9.CrossRefPubMedPubMedCentral

Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ Res. 2004;95(9):858–66.CrossRefPubMed

Zhang J, Patel L, Pienta KJ. CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis. Cytokine Growth Factor Rev. 2010;21(1):41–8.CrossRefPubMed

Ribatti D, Nico B, Crivellato E, Vacca A. Macrophages and tumor angiogenesis. Leukemia. 2007;21(10):2085–9.CrossRefPubMed

Graves DT. The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis. 1999;28(3):482–90.CrossRefPubMed

O'Hayre M, Salanga CL, Handel TM, Allen SJ. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. The Biochemical journal. 2008;409(3):635–49.CrossRefPubMed

Pahler JC, Tazzyman S, Erez N, Chen YY, Murdoch C, Nozawa H, Lewis CE, Hanahan D. Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. Neoplasia. 2008;10(4):329–40.CrossRefPubMedPubMedCentral

Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, Paloscia L, Materazzo G, D'Annunzio E, Conti P. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol. 2001;21(6):1090–1.CrossRef

10.

Daly CRB. Monnocyte chemoattractant protein-1(CCL2) in inflamaatory of disease and adaptive immunity,therapeutic opportunities and controversies. Microcirculation. 2003;10(3–4):247–57.CrossRefPubMed

11.

Raman D, Baugher PJ, Thu YM, Richmond A. Role of chemokines in tumor growth. Cancer Lett. 2007;256(2):137–65.CrossRefPubMedPubMedCentral

12.

Sambyal V, Guleria K, Kapahi R, Manjari M, Sudan M, Uppal MS, Singh NR. Association of the -2518 A/G polymorphism of MCP-1 with breast cancer in Punjab, North-West India. Asian Pac J Cancer Prev. 2015;16(16):7243–8.CrossRefPubMed

13.

Pham MHT, Bonello GB, Castiblanco J, Le T, Sigala J, He W, Mummidi S. The rs1024611 regulatory region polymorphism is associated with CCL2 allelic expression imbalance. PLoS One. 2012;7(11):e49498.CrossRefPubMedPubMedCentral

14.

Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.CrossRefPubMedPubMedCentral

15.

Wells GA, Shea BJ, O'Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis[J]. Appl Eng Agric. 2014;18(6):727–34.

16.

Attar R, Agachan B, Kuran SB, Cacina C, Sozen S, Yurdum LM, Attar E, Isbir T. Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women. In vivo. 2010;24(2):243–8.PubMed

17.

Kruszyna L, Lianeri M, Rubis B, Knula H, Rybczynska M, Grodecka-Gazdecka S, Jagodzinski PP. CCL2 -2518 A/G single nucleotide polymorphism as a risk factor for breast cancer. Mol Biol Rep. 2011;38(2):1263–7.CrossRefPubMed

18.

Wei X, Tian Y, Lu W, Li W, Zhang M, Lu X, Liu Y. Functional polymorphisms in monocyte chemoattractant protein-1 are associated with increased susceptibility to ovarian cancer. DNA Cell Biol. 2015;34(1):37–42.CrossRefPubMed

19.

Li L, Zhang J, Weng X, Wen G. Genetic variations in monocyte chemoattractant protein-1 and susceptibility to ovarian cancer. Tumour Biol. 2015;36(1):233–8.CrossRefPubMed

20.

Wu HH, Lee TH, Tee YT, Chen SC, Yang SF, Lee SK, Ko JL, Wang PH. Relationships of single nucleotide polymorphisms of monocyte chemoattractant protein 1 and chemokine receptor 2 with susceptibility and clinicopathologic characteristics of neoplasia of uterine cervix in Taiwan women. Reprod Sci. 2013;20(10):1175–83.CrossRefPubMed

21.

Zhang J, Lu Y, Pienta KJ. Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth. J Natl Cancer Inst. 2010;102(8):522–8.CrossRefPubMedPubMedCentral

22.

Conti I, Rollins BJ. CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol. 2004;14(3):149–54.CrossRefPubMed

23.

Soria G, Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 2008;267(2):271–85.CrossRefPubMed

24.

Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med. 2005;9(1):59–71.CrossRefPubMed

25.

Yang J, Lv X, Chen J, et al. CCL2–CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway:[J]. Oncotarget. 2016;7(13):15632–47.PubMed

26.

Jia LQ, Shen YC, Guo SJ, Hu QJ, Pang CS, Wang T, Chen L, Wen FQ. The 2518 A/G polymorphism in the MCP-1 gene and cancer risk: a meta-analysis. Asian Pac J Cancer Prev. 2013;14(6):3575–9.CrossRefPubMed

Title: The rs1024611 in the CCL2 gene and risk of gynecological cancer in Asians: a meta-analysis
Authors: Shuying He
Xiuzhen Zhang
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: World Journal of Surgical Oncology / Issue 1/2018
Electronic ISSN: 1477-7819
DOI: https://doi.org/10.1186/s12957-018-1335-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

The rs1024611 in the CCL2 gene and risk of gynecological cancer in Asians: a meta-analysis

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

The extremity localized classic osteosarcomas have better survival than the axial non-classics

Laparoscopic intersphincteric resection with intraoperative radiotherapy using low-energy X-rays for locally advanced ultra-low rectal cancer

A dural metastatic small cell carcinoma of the gallbladder as the first manifestation: a case report

Prognostic significance of sealed-off perforation in colon cancer: a prospective cohort study

Prognostic value of metformin for non-small cell lung cancer patients with diabetes

Two rare cases of synchronous and metachronous colonic metastases in patients with advanced gastric cancer